Carmen Scheibenbogen: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
VisualWikitext
(fix dead link, il)
(study)
Line 26: Line 26:
* 2018, Prevalence and incidence of [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] in Europe—the Euro-epiME study from the European network [[EUROMENE]]: a protocol for a systematic review<ref>{{Cite journal|last=Estévez-López|first=Fernando|author-link=Fernando Estévez-López|last2=Castro-Marrero|first2=Jesus|author-link2=Jesús Castro-Marrero|last3=Wang|first3=Xia|author-link3=Xia Wang-Steverding|last4=Bakken|first4=Inger Johanne|author-link4=Inger Johanne Bakken|last5=Ivanovs|first5=Andrejs|author-link5=Andrejs Ivanovs|last6=Nacul|first6=Luis|author-link6=Luis Nacul|last7=Sepúlveda|first7=Nuno|author-link7=Nuno Sepulveda|last8=Strand|first8=Elin B.|author-link8=Elin Strand|last9=Pheby|first9=Derek|author-link9=Derek Pheby|last10=Alegre|first10=José|author-link10=José Alegre|last11=Scheibenbogen|first11=Carmen|author-link11=Carmen Scheibenbogen|last12=Shikova|first12=Evelina|author-link12=Evelina Shikova|last13=Lorusso|first13=Lorenzo|author-link13=Lorenzo Lorusso|last14=Capelli|first14=Enrica|author-link14=Enrica Capelli|last15=Sekulic|first15=Slobodan|author-link15=Slobodan Sekulic|last16=Lacerda|first16=Eliana|author-link16=Eliana Lacerda|last17=Murovska|first17=Modra|author-link17=Modra Murovska|date=2018-09-01|title=Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review|url=https://bmjopen.bmj.com/content/8/9/e020817|journal=BMJ Open|language=en|volume=8|issue=9|pages=e020817|doi=10.1136/bmjopen-2017-020817|issn=2044-6055|pmc=|pmid=30181183|via=}}</ref> - [https://bmjopen.bmj.com/content/8/9/e020817 (Full text)]
* 2018, Prevalence and incidence of [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] in Europe—the Euro-epiME study from the European network [[EUROMENE]]: a protocol for a systematic review<ref>{{Cite journal|last=Estévez-López|first=Fernando|author-link=Fernando Estévez-López|last2=Castro-Marrero|first2=Jesus|author-link2=Jesús Castro-Marrero|last3=Wang|first3=Xia|author-link3=Xia Wang-Steverding|last4=Bakken|first4=Inger Johanne|author-link4=Inger Johanne Bakken|last5=Ivanovs|first5=Andrejs|author-link5=Andrejs Ivanovs|last6=Nacul|first6=Luis|author-link6=Luis Nacul|last7=Sepúlveda|first7=Nuno|author-link7=Nuno Sepulveda|last8=Strand|first8=Elin B.|author-link8=Elin Strand|last9=Pheby|first9=Derek|author-link9=Derek Pheby|last10=Alegre|first10=José|author-link10=José Alegre|last11=Scheibenbogen|first11=Carmen|author-link11=Carmen Scheibenbogen|last12=Shikova|first12=Evelina|author-link12=Evelina Shikova|last13=Lorusso|first13=Lorenzo|author-link13=Lorenzo Lorusso|last14=Capelli|first14=Enrica|author-link14=Enrica Capelli|last15=Sekulic|first15=Slobodan|author-link15=Slobodan Sekulic|last16=Lacerda|first16=Eliana|author-link16=Eliana Lacerda|last17=Murovska|first17=Modra|author-link17=Modra Murovska|date=2018-09-01|title=Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review|url=https://bmjopen.bmj.com/content/8/9/e020817|journal=BMJ Open|language=en|volume=8|issue=9|pages=e020817|doi=10.1136/bmjopen-2017-020817|issn=2044-6055|pmc=|pmid=30181183|via=}}</ref> - [https://bmjopen.bmj.com/content/8/9/e020817 (Full text)]
*2018, Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)<ref>{{Cite journal|last=Rasa|first=Santa|author-link=Santa Rasa|last2=Nora-Krukle|first2=Zaiga|author-link2=Zaiga Nora-Krukle|last3=Henning|first3=Nina|author-link3=|last4=Eliassen|first4=Eva|author-link4=|last5=Shikova|first5=Evelina|author-link5=Evelina Shikova|last6=Harrer|first6=Thomas|author-link6=Thomas Harrer|last7=Scheibenbogen|first7=Carmen|author-link7=Carmen Scheibenbogen|last8=Murovska|first8=Modra|author-link8=Modra Murovska|last9=Prusty|first9=Bhupesh K.|author-link9=Bhupesh Prusty|last10=European Network on ME/CFS (EUROMENE)|first10=|author-link10=EUROMENE|date=2018-10-01|title=Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1644-y|journal=Journal of Translational Medicine|language=En|volume=16|issue=1|pages=|doi=10.1186/s12967-018-1644-y|issn=1479-5876|pmc=|pmid=30285773|quote=|via=}}</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1644-y (Full text)]
*2018, Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)<ref>{{Cite journal|last=Rasa|first=Santa|author-link=Santa Rasa|last2=Nora-Krukle|first2=Zaiga|author-link2=Zaiga Nora-Krukle|last3=Henning|first3=Nina|author-link3=|last4=Eliassen|first4=Eva|author-link4=|last5=Shikova|first5=Evelina|author-link5=Evelina Shikova|last6=Harrer|first6=Thomas|author-link6=Thomas Harrer|last7=Scheibenbogen|first7=Carmen|author-link7=Carmen Scheibenbogen|last8=Murovska|first8=Modra|author-link8=Modra Murovska|last9=Prusty|first9=Bhupesh K.|author-link9=Bhupesh Prusty|last10=European Network on ME/CFS (EUROMENE)|first10=|author-link10=EUROMENE|date=2018-10-01|title=Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1644-y|journal=Journal of Translational Medicine|language=En|volume=16|issue=1|pages=|doi=10.1186/s12967-018-1644-y|issn=1479-5876|pmc=|pmid=30285773|quote=|via=}}</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1644-y (Full text)]
*2020, IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS<ref>https://doi.org/10.1016/j.bbih.2020.100047</ref> - [https://www.sciencedirect.com/science/article/pii/S2666354620300120 (Full text)]


==Clinic location==
==Clinic location==

Revision as of 16:49, April 3, 2020

Source:Invest in ME

Professor Doctor Carmen Scheibenbogen is an Internal Medicine physician, ME/CFS doctor and the Professor for Immunology and Deputy Chair, Institute of Medical Immunology, at the University Hospital Charité in Berlin, Germany. Her research focuses on the role of Epstein-Barr virus (EBV), particularly the characterization of EBV specific B cell and T cell response and the enhanced antibody response against EBV peptides in myalgic encephalomyelitis (ME) versus healthy controls.[1]

EUROMENE[edit | edit source]

Professor Scheibenbogen is the Leader of the Biomarkers Working Group of EUROMENE, a European Union, COST Action CA15111, not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[2]

Diagnostic test[edit | edit source]

Professor Scheibenbogen helped create the CellTrend Diagnostic Test which may help identify a subset of 20-30% of all patients with ME/CFS. These patients have elevated levels of three auto-antibodies, i.e., against the b2-adrenergic receptor, against the muscarinic cholinergic receptor 3 (M3) and against the muscarinic cholinergic receptor 4 (M4).[3]

Awards[edit | edit source]

Notable studies[edit | edit source]

Clinic location[edit | edit source]

  • Charité University Medicine, Berlin, Germany

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ "Invest in ME Research - International ME Conferences and Colloquiums Home Page". investinme.org. Retrieved November 14, 2019.
  2. ↑ "Action CA15111". COST. Retrieved November 14, 2019.
  3. ↑ "POTS - CFS/ME - CRPS". CellTrend Luckenwalde. Retrieved February 18, 2020.
  4. ↑ "2016 Ramsay Award Program Results". Solve ME/CFS Initiative. Retrieved November 14, 2019.
  5. ↑ "2017 Ramsay Award Program Results". Solve ME/CFS Initiative. Retrieved November 14, 2019.
  6. ↑ Loebel, Madlen; Strohschein, Kristin; Giannini, Carolin; Koelsch, Uwe; Bauer, Sandra; Doebis, Cornelia; Thomas, Sybill; Unterwalder, Nadine; von Baehr, Volker; Reinke, Petra; Knops, Michael; Hanitsch, Leif G.; Meisel, Christian; Volk, Hans-Dieter; Scheibenbogen, Carmen (January 15, 2014), "Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome", PLoS One, doi:10.1371/journal.pone.0085387
  7. ↑ Guenther, Sabrina; Loebel, Madlen; Mooslechner, Agnes A; Knops, Michael; Hanitsch, Leif G; Grabowski, Patricia; Wittke, Kirsten; Meisel, Christian; Unterwalder, Nadine; Volk, Hans-Dieter; Scheibenbogen, Carmen (2015), "Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome", Human Immunology, 76 (10): 729-35, doi:10.1016/j.humimm.2015.09.028
  8. ↑ Loebel, Madlen; Mooslechner, Agnes Anna; Bauer, Sandra; Günther, Sabrina; Letsch, Anne; Hanitsch, Leif G; Grabowski, Patricia; Meisel, Christian; Volk, Hans-Dieter; Scheibenbogen, Carmen (2015), "Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome", Journal of Translational Medicine, 13, doi:10.1186/s12967-015-0628-4
  9. ↑ Loebel, M; Grabowski, P; Heidecke, H; Bauer, S; Hanitsch, LG; Wittke, K; Meisel, C; Reinke, P; Volk, H; Fluge, Ø; Mella, O; Scheibenbogen, C (2016), "Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome", Brain, behavior, and immunity, 52: 32-39, doi:10.1016/j.bbi.2015.09.013
  10. ↑ Loebel, Madlen; Eckey, Maren; Sotzny, Franziska; Hahn, Elisabeth; Bauer, Sandra; Grabowski, Patricia; Zerweck, Johannes; Holenya, Pavlo; Hanitsch, Leif G.; Wittke, Kirsten; Borchmann, Peter; Rüffer, Jens-Ulrich; Hiepe, Falk; Ruprecht, Klemens; Behrends, Uta; Meindl, Carola; Volk, Hans-Dieter; Reimer, Ulf; Scheibenbogen, Carmen (2017), "Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray", PLOS ONE, 12 (6): e0179124, doi:10.1371/journal.pone.0179124
  11. ↑ Scheibenbogen, Carmen; Freitag, Helma; Blanco, Julià; Capelli, Enrica; Lacerda, Eliana; Authier, Jerome; Meeus, Mira; Castro Marrero, Jesus; Nora-Krukle, Zaiga; Oltra, Elisa; Strand, Elin Bolle; Shikova, Evelina; Sekulic, Slobodan; Murovska, Modra (July 26, 2017). "The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE". Journal of Translational Medicine. 15 (1). doi:10.1186/s12967-017-1263-z. ISSN 1479-5876. PMC 5530475. PMID 28747192.
  12. ↑ Sotzny, Franziska; Blanco, Julià; Capelli, Enrica; Castro-Marrero, Jesús; Steiner, Sophie; Murovska, Modra; Scheibenbogen, Carmen (2018), "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease", Autoimmunity Reviews, doi:10.1016/j.autrev.2018.01.009
  13. ↑ Scheibenbogen, Carmen; Loebel, Madlen; Freitag, Helma; Krueger, Anne; Bauer, Sandra; Antelmann, Michaela; Doehner, Wolfram; Scherbakov, Nadja; Heidecke, Harald; Reinke, Petra; Volk, Hans-Dieter; Grabowski, Patricia (2018). "Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME". PLoS ONE. 13 (3): e0193672. doi:10.1371/journal.pone.0193672.
  14. ↑ Yang, Chin-An; Bauer, Sandra; Ho, Yu-Chen; Sotzny, Franziska; Chang, Jan-Gowth; Scheibenbogen, Carmen (August 17, 2018). "The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome". Journal of Translational Medicine. 16 (1). doi:10.1186/s12967-018-1600-x. ISSN 1479-5876.
  15. ↑ Estévez-López, Fernando; Castro-Marrero, Jesus; Wang, Xia; Bakken, Inger Johanne; Ivanovs, Andrejs; Nacul, Luis; Sepúlveda, Nuno; Strand, Elin B.; Pheby, Derek; Alegre, José; Scheibenbogen, Carmen; Shikova, Evelina; Lorusso, Lorenzo; Capelli, Enrica; Sekulic, Slobodan; Lacerda, Eliana; Murovska, Modra (September 1, 2018). "Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review". BMJ Open. 8 (9): e020817. doi:10.1136/bmjopen-2017-020817. ISSN 2044-6055. PMID 30181183.
  16. ↑ Rasa, Santa; Nora-Krukle, Zaiga; Henning, Nina; Eliassen, Eva; Shikova, Evelina; Harrer, Thomas; Scheibenbogen, Carmen; Murovska, Modra; Prusty, Bhupesh K.; European Network on ME/CFS (EUROMENE) (October 1, 2018). "Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)". Journal of Translational Medicine. 16 (1). doi:10.1186/s12967-018-1644-y. ISSN 1479-5876. PMID 30285773.
  17. ↑ https://doi.org/10.1016/j.bbih.2020.100047

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

autoantibody An antibody that works against the body's own antigens, a hallmark of autoimmune diseases. Autoantibodies are the opposite of an antibodies.

cholinergic Involving the neurotransmitter acetylcholine. Cholinergic side effects include diarrhea, blurred vision, decreased intraocular pressure, contricted pupil in the eyes, sweating, increased saliva and mucus on the lungs, bronchial constriction, increased gastrointestinal tone, decreased blood pressure, slow heart rate, and contraction of bladder detrusor muscle. muscle spasms/cramps, low blood pressure, slowed heart rate, nausea and vomiting, increased saliva and sweating, shortness of breath, and urinating more often.

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

β β / Β. Greek letter beta (a symbol used in science), equivalent to "b".

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

BMJ The BMJ (previously the British Medical Journal) is a weekly peer-reviewed medical journal.

Retrieved from "https://me-pedia.org/w/index.php?title=Carmen_Scheibenbogen&oldid=80789"